The global fusion biopsy market, valued at US$0.61 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching ...
Two new techniques have been key to the reduction in harm – multiparametric MRI scans and transperineal guided biopsies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback